Shinpoong Gentamicin Injection 80 mg
Gentamicin Sulfate 80mg
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
MFDS item code 198600034 · Notified 1986.09.29 · Insurance code 648501841
Treatment of bacterial infections (e.g., sepsis and meningitis); initial treatment of infections of unknown cause
This medication is used for the treatment of various infections including sepsis, central nervous system infections, urinary tract infections, respiratory infections, gastrointestinal infections, and skin and soft tissue infections. It is particularly effective against several bacteria including Pseudomonas, E. coli, and Staphylococcus, including resistant strains. It can also be utilized in the initial treatment along with other antibiotics when the causative bacteria are not clearly identified. Additionally, it is used in combination for the treatment of endocarditis and life-threatening Pseudomonas infections. This medication aids in the rapid and effective treatment of various bacterial infections, thus helping improve the patient's symptoms of infection.
1. Patients with normal renal function The usual treatment duration is 7~10 days and may be extended in severe or refractory cases. 1) Adults: Administer gentamicin 3mg (potency) per kg of body weight per day in divided doses every 8 hours by intravenous or intramuscular injection. In life-threatening cases, administer 5mg (potency) per kg of body weight per day in 3~4 divided doses. Reduce the dose as symptoms improve. At this time, it is preferable that the peak serum concentration not exceed 12㎍/mL and the trough serum concentration (immediately before the next dose) not exceed 2㎍/mL. <Table 1> Body weight (Kg) / Usual dose for severe infection (1mg/Kg every 8 hours) / Dose for life-threatening cases (1.7mg/Kg every 8 hours) 40 / 1.0mL(40mg) / 1.6mL(66mg) 45 / 1.1mL(45mg) / 1.9mL(75mg) 50 / 1.25mL(50mg) / 2.1mL(83mg) 55 / 1.4mL(55mg) / 2.25mL(91mg) 60 / 1.5mL(60mg) / 2.5mL(100mg) 65 / 1.6mL(65mg) / 2.7mL(108mg) 70 / 1.75mL(70mg) / 2.9mL(116mg) 75 / 1.9mL(75mg) / 3.1mL(125mg) 80 / 2.0mL(80mg) / 3.3mL(133mg) 85 / 2.1mL(85mg) / 3.5mL(141mg) 90 / 2.25mL(90mg) / 3.75mL(150mg) 95 / 2.4mL(95mg) / 4.0mL(158mg) 100 / 2.5mL(100mg) / 4.2mL(166mg) ※ Intravenous injection Administer intravenously to patients for whom intramuscular injection is inappropriate, such as those with sepsis, shock, congestive heart failure, hematologic disorders, severe burns, or reduced muscle mass. The dose is the same as for intramuscular injection, but dilute it as follows and administer separately without mixing it with other drugs. For intermittent intravenous infusion, dilute each dose in 50~200mL of saline or 5% dextrose injection and infuse intravenously over 30 minutes~2 hours. 2. Patients with renal impairment 1) Adjust the dose in patients with renal impairment according to the degree of renal dysfunction. <Table 2> Dose adjustment in patients with renal impairment (dose at 8-hour intervals after the initial dose) Serum creatinine (mg %) / Approximate creatinine clearance (mL/min/1.73㎡) / Percentage of the dose for patients with normal renal function ≤ 1.0 / > 100 / 100 1.1 ~ 1.3 / 70 ~ 100 / 80 1.4 ~ 1.6 / 55 ~ 70 / 65 1.7 ~ 1.9 / 45 ~ 55 / 55 2.0 ~ 2.2 / 40 ~ 45 / 50 2.3 ~ 2.5 / 35 ~ 40 / 40 2.6 ~ 3.0 / 30 ~ 35 / 35 3.1 ~ 3.5 / 25 ~ 30 / 30 3.6 ~ 4.0 / 20 ~ 25 / 25 4.1 ~ 5.1 / 15 ~ 20 / 20 5.2 ~ 6.6 / 10 ~ 15 / 15 6.7 ~ 8.0 / < 10 / 10 Since the serum half-life of gentamicin is closely related to the serum creatinine concentration, the dosing interval can be roughly estimated by multiplying the serum creatinine concentration (mg/100mL) by 8. 2) Patients with renal impairment and severe systemic infection: It is preferable to reduce the dose and increase the frequency of administration. Check the serum gentamicin concentration in these patients to adjust the dose. Use the usual dose for patients with normal renal function as the initial dose; subsequent doses (administered every 8 hours) can be roughly calculated by dividing the usual recommended dose by the serum creatinine concentration. 3) In patients undergoing hemodialysis, administer 1~1.7mg (potency) per kg of body weight to adults at the end of each dialysis session. 3. Urinary tract infections For urinary tract infections in patients with normal renal function, 160mg (potency) may be administered once daily. Adjust the dose according to age and symptoms.
2) Children: Administer 6~7.5mg (potency) per kg of body weight per day in divided doses every 8 hours by intravenous or intramuscular injection. 3) Infants: Administer 7.5mg (potency) per kg of body weight per day in divided doses every 8 hours by intravenous or intramuscular injection. 4) Premature infants and neonates less than 1 week old: Administer 5mg (potency) per kg of body weight per day in divided doses every 12 hours by intravenous injection. 5) The safety of intravenous infusion has not been established in premature infants, neonates, infants, young children, or children. 6) The safety of intramuscular injection has not been established in premature infants or neonates. For infants and children, adjust the amount of the drug in the diluent appropriately. 3) In children undergoing hemodialysis, administer 2mg (potency) per kg of body weight at the end of each dialysis session.
This medication should be handled very carefully when using ampoules as glass fragments may be mixed in. Special care is needed when used in children and the elderly. It should not be used in patients allergic to aminoglycosides or those with hypersensitivity to bacitracin, and in pregnant or nursing women. It should be administered with caution in patients with a history of hearing loss, or with kidney or liver problems, newborns, and premature infants, as well as elderly patients with poor general health or muscle disorders. This medication can cause allergic reactions, particularly in asthma patients where the symptoms may worsen. During administration, adverse effects such as shock, allergic reactions, neurological symptoms (dizziness, tinnitus, hearing loss, etc.), gastrointestinal symptoms, difficulty breathing, blood abnormalities, and changes in liver and kidney functions may occur, hence careful monitoring is required. Long-term use or high doses may increase the risk of hearing loss and kidney function decline, thus the duration of use should preferably not exceed 10 days, and hearing tests and kidney function tests should be conducted if necessary. It is especially important to measure serum drug levels in elderly patients or those with impaired kidney function to adjust the dosage and administration intervals. Adequate hydration should be maintained during administration to prevent dehydration, and caution should be exercised when combined with certain blood substitutes, diuretics, anesthetics, or muscle relaxants, as renal toxicity or respiratory depression risks may increase. It is safest not to use this medication in pregnant or nursing women, as administration during pregnancy may result in serious side effects such as hearing loss in newborns. Newborns and premature infants should be administered with care as their kidney function may be immature, potentially leading to elevated drug levels. In cases of overdose, renal dysfunction, hearing impairment, neuromuscular blockade, and respiratory paralysis may occur requiring appropriate treatment and dialysis. Pain or induration may occur at the injection site, hence it is advisable to sufficiently massage the local area post-injection. This medication may interact with other antibiotics or drugs, hence it should only be used after consulting with medical personnel.
shock
Not everyone experiences these, and they can vary from person to person.
This medication is stored in a light-blocking sealed container. Store at room temperature, maintaining a temperature between 1 and 30 degrees Celsius. Ampoule forms of the medication should also be stored in a sealed container, and it is likewise important to keep it at room temperature.
A brown vial containing a colorless transparent liquid or a colorless transparent ampoule injection.
2 mL/ampoule x 50
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Gentamicin Sulfate 80mg
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Gentamicin Sulfate
Prescription medication
International Pharmaceutical Co., Ltd.
Gentamicin Sulfate 80mg
Injections · Prescription medication
Albozen Korea Co., Ltd.
Gentamicin Sulfate 1mg
Cream · OTC medication
Shinpoong Pharmaceutical Co., Ltd.
Gentamicin Sulfate
Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Gentamicin Sulfate
Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.
Gentamicin Sulfate 1mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Gentamicin Sulfate 40mg
Prescription medication
Humedics Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.